Autopsy report · NCT03150524

RCVS: The Rational Approach to Diagnosis and Treatment

“Failure to recruit patients meeting inclusion criteria.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

Johns Hopkins University

Sponsor type

University, hospital or other

Conditions

Reversible Cerebral Vasoconstriction Syndrome

Interventions

TCD- cerebral blood flow velocities; Headache pain score; Neurological examination; Repeat Neuroimaging; Nimodipine; Verapamil ER

Participants

0

Sites

2

Countries

United States

Trials that died the same way

• Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric Cancer
  “Too narrow inclusion criteria. Impossible to recruit patients.” (86% match in meaning)
• Safety and Efficacy of Intranasal Administration of Niclosamide (UNI91103) in Adults With Asymptomatic or Mild COVID-19
  “Failure of recruiting patients” (83% match in meaning)
• Rehabilitation in Aortic Stenosis Patients
  “Slow inclusion rate, failure to recruit a priori determined no of patients.” (81% match in meaning)
• Neuropsychological Effects of Hydrocortisone in Patients With Partial Adrenal Insufficiency
  “Insufficient recruitment of suitable patients.” (78% match in meaning)
• Radical Lung Radiotherapy Plus Nelfinavir
  “failed to recruit, no suitable patients” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.